Search Results

Business

Marizyme, Inc., Agrees to Distribute Somahlution’s DuraGraft Products in South America and Mexico

Marizyme, Inc., a publicly traded company focused on acquiring late-stage drug assets to develop for use in the acute care space, announced that they have agreed to exclusively distribute Somahlution’s DuraGraft® products in Mexico and South America.

October 11, 2019

·

4 min read

Somahlution Announces Site Initiation and Patient Enrollment in United Kingdom for European DuraGraft Registry

Somahlution today announced that Golden Jubilee National Hospital and Victoria Blackpool Hospital in the United Kingdom have initiated patient enrollment in the DuraGraft European Registry clinical trial.

February 13, 2018

·

5 min read

Somahlution Announces Patient Enrollment In Duragraft CABG European Registry

January 4, 2017

·

2 min read

Somahlution Announces Duragraft Registry Initiation At Leading Cardiac Surgery Hospitals In Germany

May 30, 2017

·

2 min read

Business

Somahlution Announces Medical University of Vienna As First Austrian Site To Participate In Duragraft Registry

May 5, 2017

·

2 min read

Somahlution Announces Multiple Site Initiation And Patient Enrollment In Spain For European DuraGraft Registry

February 2, 2017

·

2 min read

Somahlution Announces Study Results Showing DuraGraft Vascular Graft Treatment Improves Long-Term Outcomes in Coronary Artery Bypass Grafting Surgery

October 4, 2016

·

3 min read

Business

BioLife Solutions, Inc. Announces Manufacturing Agreement With Somahlution LLC

July 17, 2014

·

4 min read

FDA

Somahlution Announces CE Mark And European Launch Of DuraGraft® Vascular Conduit Solution

September 23, 2014

·

1 min read

Marizyme Inc. Announces Results of GOAL Study Presented at 7th Annual International Coronary Congress

Marizyme Inc. (MRZM), announced today that results of the GOAL Study (Vienna Heart Center Floridsdorf/PI Dr. Winkler Bernhard) were presented by Dr. Maximillian Y. Emmert (German Heart Center and Charite Universitatsmedizin, Berlin Germany) Friday, December 3 at the 7th Annual International Coronary Congress in New York City.

December 3, 2021

·

4 min read